You're reading a supplement label, and there it is near the bottom: "Vitamin K2 (as MK-7)." Or maybe it just says "Vitamin K2," with no form listed at all. If you've ever wondered whether that little detail actually matters — or whether K2 is one of those nutrients that sounds important but quietly does nothing — you're asking a reasonable question.
Here's the good news: vitamin K2 has a clear, well-described job in the body, and the form does matter in ways that are easy to understand once someone explains them plainly. This is one of those nutrients where a few minutes of reading pays off.
This post walks through what K2 does, why the MK-7 form gets singled out, and why women in perimenopause and menopause in particular may want to pay attention to it.
Quick Answers
- If you already take vitamin D3 and want a calcium-routing partner → consider pairing it with vitamin K2 (MK-7).
- If you're comparing K2 supplements → look for a label that names the form. In a small study in healthy women, MK-7 stayed measurable in the blood for up to 48 hours after one dose, while the same dose of MK-4 wasn't detectable (see MK-7 vs MK-4).
- If you're in perimenopause or menopause → K2 is worth knowing about, since bone metabolism shifts during this transition.
- If a label just says "Vitamin K" with no form or dose → that's a reason to look closer.
- If you eat natto regularly → you're already getting a meaningful dietary MK-7 source.
Vivi's Lumera includes K2 in the MK-7 form as one piece of a broader foundational formula — more on where that could fit below.
What Is Vitamin K2 (MK-7)?
Vitamin K comes in two main families. K1 (phylloquinone) shows up mostly in leafy greens and is best known for its role in blood clotting. K2 (menaquinone) is a different branch, and it's the one tied to where your body puts calcium.
K2 itself comes in several subtypes, named by the length of their side chain — MK-4, MK-7, and so on. MK-7 is the long-chain version found in fermented foods like natto. The practical difference is how long it stays in your bloodstream. MK-7 has a much longer half-life than vitamin K1, so daily intake builds steadier blood levels instead of clearing out quickly.¹
K2's main role is activating proteins that manage calcium, including osteocalcin in bone. Think of K2 less as a building block and more as a traffic director for calcium.
Important: If you take a blood thinner such as warfarin, talk to your clinician before taking vitamin K. Vitamin K interacts with how those drugs work, and a sudden change in how much you get can cause dangerous bleeding or blood clots.² This is a genuine interaction, not a precaution to skim past.
The Forms and Factors That Matter
MK-7 vs MK-4: the form question
What it does: Both are vitamin K2, but they aren't interchangeable. MK-7 is the long-chain form found in fermented foods like natto. MK-4 is a short-chain form, and it's the one your body can make from vitamin K1. The number refers to the length of the molecule's side chain, and that's what separates them.³
Why it's relevant: For a once-daily supplement, you want a form that stays available in the blood between doses, and you want to know whether the form on your label is the one used in the research you're reading about.
Half-life: In healthy volunteers, natto-derived MK-7 reached higher, more sustained blood levels than vitamin K1, with a much longer half-life.¹ That study compared MK-7 with K1, not with MK-4.
Blood levels, MK-7 vs MK-4: In a small study in healthy women, a single 420 µg dose of MK-7 was well absorbed. Blood levels peaked about 6 hours later and were still detectable up to 48 hours later. The same dose of MK-4 wasn't detectable in the blood at any time point. When the women took 60 µg a day for 7 days, MK-7 raised blood MK-7 levels in every participant, and MK-4 at the same amount did not.⁴ The study measured blood levels, not bone or heart outcomes, and one author worked for a company lab.⁴
Dosing: The long-term MK-7 trials cited in this post used 180 µg a day⁵ and 375 µg a day.⁶ Those are study doses, not a universal standard, so check the microgram amount on your own label.
The MK-4 doses you'll see in older Japanese research are pharmacological: 45 mg a day, used there as a prescription osteoporosis treatment.³ That's a drug dose, not a supplement serving.
Research in women: In healthy postmenopausal women, 180 µg a day of MK-7 for 3 years helped limit age-related decline in bone mineral density compared with placebo.⁵ In postmenopausal women with lower bone density, 375 µg a day for 3 years improved osteocalcin carboxylation, a marker of K2 activity, while bone-density results were mixed.⁶ Both trials used MK-7. Much of the older MK-4 research was done in Japan, mostly in postmenopausal women, at 15–45 mg a day.³
| MK-7 | MK-4 |
|---|---|
| Side chain: long (the "7"); found in natto | Side chain: short (the "4") |
| Blood levels: much longer half-life than vitamin K1¹; still detectable 48 hours after a single 420 µg dose⁴ | Blood levels: not detectable after the same 420 µg dose, and no rise with 60 µg/day for 7 days⁴ |
| Doses in the research: 180 µg/day⁵ and 375 µg/day⁶ in the long-term trials cited here | Doses in the research: 45 mg/day is a prescription drug dose in Japan,³ not a supplement amount |
| Long-term research in postmenopausal women: two 3-year placebo-controlled trials⁵,⁶ | Research in women: older trials, mostly Japanese and mostly in postmenopausal women, at 15–45 mg/day³ |
| On the label: "Vitamin K2 (as MK-7)" plus a microgram amount | On the label: "Vitamin K2 (as MK-4)" plus an amount |
Calcium routing
What it does: Vitamin K is a cofactor for proteins that handle calcium, including osteocalcin in bone and matrix Gla protein in cartilage and blood-vessel walls.¹
Why it's relevant: This is the mechanism behind the "K2 helps put calcium where you want it" idea.
Evidence note: This calcium-routing role is well-described mechanistically and forms the foundation of K2's structure-function story.
The K2 and D3 partnership
What it does: Vitamin D3 supports calcium absorption from the gut. K2 helps direct that calcium once it's in circulation. They work on different steps of the same process.
Why it's relevant: Taking D3 without attention to K2 status means handling one half of the calcium story.
Evidence note: Combination studies have examined D3 alongside vitamin K and other nutrients for bone support in postmenopausal women, though isolated effects are hard to separate in blended formulas.⁷
Bone metabolism around menopause
What it does: K2 activates osteocalcin, a protein involved in bone maintenance.
Why it's relevant: Bone turnover shifts during and after the menopausal transition, which makes K2 status more worth attention in this stage.
Evidence note: A 3-year trial in healthy postmenopausal women found daily MK-7 helped reduce age-related decline in bone mineral density.⁵ A later trial in women with lower bone density showed improved osteocalcin carboxylation, with more mixed density outcomes.⁶
What Actually Matters in a K2 MK-7 Supplement
1. A clearly stated MK-7 form
- Best for: anyone who wants a once-daily K2 that stays in the blood longer.
- Why it's here: MK-7's long half-life makes it practical for daily dosing.¹
- How to choose: the label should say "K2 (as MK-7)," not just "Vitamin K."
2. A meaningful, stated dose
- Best for: people who read labels and want real amounts.
- Why it's here: long-term research in postmenopausal women has used doses around 180 µg/day.⁵
- How to choose: look for the microgram amount printed clearly, not buried in a blend.
3. Pairing with D3 (and often magnesium)
- Best for: anyone already taking vitamin D.
- Why it's here: D3 and K2 work on different steps of calcium handling.
- How to choose: a formula that includes both is convenient; just confirm each is dosed and disclosed.
4. Trademarked, traceable K2 material
- Best for: skeptics who want supply-chain integrity.
- Why it's here: a named, trademarked ingredient (like K2Vital) tells you exactly which MK-7 material is in the product.
- How to choose: look for the ingredient's name on the label, not just "vitamin K2."
How to Choose the Right Vitamin K2 Supplement
- If you already take vitamin D3 → consider a K2 (MK-7) to support the calcium-routing side of the equation.
- If you're in perimenopause or menopause → consider attention to K2 status as part of a foundational nutrient approach.
- If you take a blood thinner → talk to your clinician before adding any vitamin K.
- If a label hides the form or dose in a proprietary blend → consider looking elsewhere.
Quality rules (non-negotiable):
- Transparent dosing — exact micrograms, no proprietary blends hiding the K2 amount.
- Evidence-aligned forms — MK-7 rather than unspecified "Vitamin K," and active partners like D3.
When to Expect Results + Lifestyle Multipliers
Timeline (realistic expectations)
K2 isn't something you feel. Its work happens at the level of proteins and calcium handling, not mood or energy. Researchers track markers like osteocalcin carboxylation alongside bone density, and the long-term trials cited here ran for 3 years.⁵,⁶ Translation: this is a long-game, foundational nutrient, not a same-week experience.
Lifestyle multipliers (high ROI)
- Weight-bearing movement: walking, resistance work, and load-bearing activity matter for bone, alongside any nutrient.
- Vitamin D status: many postmenopausal women run low, so a simple 25(OH)D blood test is sensible.⁸
- Protein and overall diet quality: the raw materials matter.
- Not smoking, and keeping alcohol moderate.
Where Lumera Could Fit
Lumera is built as a daily foundation for women navigating perimenopause and menopause. It contains K2Vital, an MK-7 form of vitamin K2, alongside vitamin D3 and magnesium, so the calcium-handling partners sit in one daily formula (2 capsules) rather than scattered across separate bottles.
If you're in the menopausal transition and thinking about foundational nutrient support — including the D3-and-K2 pairing this post described — consider exploring Lumera as a daily base that uses active, disclosed ingredient forms. It's designed as a daily nutrient base for the menopausal transition, working alongside whatever else you and your clinician are doing.
If you take a blood thinner such as warfarin, talk to your clinician before taking Lumera or any vitamin K supplement.²
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FAQs
Is vitamin K2 really different from the K1 in leafy greens?
Yes. K1 is tied mainly to blood clotting; K2 (menaquinone) is more associated with activating proteins that handle calcium, such as osteocalcin in bone. They're related but play different roles.¹
Is MK-7 actually better than MK-4?
"Better" depends on the goal. MK-7 has a much longer half-life than vitamin K1,¹ which makes it practical for once-daily dosing, and it's the form used in the long-term trials in postmenopausal women cited here.⁵,⁶ In one small study, nutritional doses of MK-4 (420 µg once, or 60 µg a day for a week) didn't raise blood MK-4 levels, while the same doses of MK-7 did.⁴ See the MK-7 vs MK-4 comparison above.
How much K2 MK-7 do studies use?
Long-term research in postmenopausal women has used around 180 µg/day.⁵ Check any product's label for its stated microgram amount.
Which form of K2 did the long-term studies in women use?
MK-7. The two 3-year trials cited in this post used 180 µg a day in healthy postmenopausal women and 375 µg a day in postmenopausal women with lower bone density.⁵,⁶ If a label lists MK-4 instead, check the amount and ask the brand which research it's following.
Why do women in perimenopause and menopause hear more about K2?
Bone turnover shifts during and after the menopausal transition, which makes nutrients tied to bone metabolism — like K2 — more relevant to pay attention to during this stage.⁵
Do I need to take D3 and K2 together?
They complement each other: D3 supports calcium absorption, and K2 activates proteins that handle calcium. Many people who take D3 add K2 for that reason, though they don't have to be in the same pill.
Can I just eat food instead of supplementing?
Natto, a fermented soybean food, is a rich dietary source of MK-7: 3 ounces provide about 850 mcg.³ If you eat it regularly, you're getting a meaningful amount.
Is it safe to take K2 every day?
Vitamin K has not been shown to cause harm, but it can interact with some medications, particularly warfarin.² If you take a blood thinner such as warfarin, talk to your clinician before taking vitamin K, because a sudden change in how much you get can affect how the medication works.²
How long before K2 "does something"?
K2 is a foundational nutrient you won't feel day to day. In research, bone-related measures are tracked over months to years; the long-term trials cited here ran for 3 years.⁵
References
- Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-3283. https://pubmed.ncbi.nlm.nih.gov/17158229/ (human clinical trial)
- National Institutes of Health, Office of Dietary Supplements. Vitamin K: Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/VitaminK-Consumer/ (regulatory/agency)
- National Institutes of Health, Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/ (regulatory/agency)
- Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93. https://pubmed.ncbi.nlm.nih.gov/23140417/ (human clinical trial)
- Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24:2499-2507. https://pubmed.ncbi.nlm.nih.gov/23525894/ (human RCT)
- Rønn SH, et al. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporos Int. 2021;32:185-191. https://pubmed.ncbi.nlm.nih.gov/33030563/ (human RCT)
- Lappe J, et al. Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study. Eur J Nutr. 2013;52(1):203-215. https://pubmed.ncbi.nlm.nih.gov/22302614/ (human RCT)
- Xie Z, et al. Prevalence of Vitamin D Inadequacy Among Chinese Postmenopausal Women: A Nationwide, Multicenter, Cross-Sectional Study. Front Endocrinol. 2019;9:782. https://doi.org/10.3389/fendo.2018.00782 (observational)